Bruker's minispec Whole Body Composition Analyzer based on TD-NMR provides a precise method for measurement of lean tissue, fat and fluid in living mice and rats. This body composition analyzer ...
Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Download Brochure Bruker's minispec Whole Body Composition ...
14h
Zacks Investment Research on MSNBioSpin's Innovations to Support Bruker Shares, Macro Issues to AilBruker’s BRKR strong growth reflects its fundamental commitment to innovate high-value solutions and ongoing portfolio transformation. Yet, the company’s operations face the wrath of excessive ...
StockStory.org on MSN1d
Research Tools & Consumables Stocks Q4 Recap: Benchmarking Bruker (NASDAQ:BRKR)Wrapping up Q4 earnings, we look at the numbers and key takeaways for the research tools & consumables stocks, including ...
With modern patients demanding higher levels of comfort, convenience, and precision, dental fluorescence analyzers have emerged as a preferred diagnostic tool. Their non-invasive nature, rapid ...
Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...
timsTOF was engineered by Bruker experts as an open platform to accelerate the adoption of ion mobility-mass spectrometry analysis across research applications. All that is missing are your ...
Is Bruker a buy or sell going into earnings? Read our full analysis here, it’s free. This quarter, analysts are expecting Bruker’s revenue to grow 13.1% year on year to $966.1 million ...
Bruker Corporation BRKR recently launched the new X4 POSEIDON, a high-performance 3D X-ray microscope (XRM) using ...
Frank Laukien, President and CEO, reported that Bruker achieved Q4 2024 constant exchange rate (CER) revenue growth of 15.8%, with reported revenues reaching $979.6 million and organic growth of 3.9%.
M&T Bank Corp lifted its stake in Bruker Co. (NASDAQ:BRKR – Free Report) by 303.1% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 17,870 shares of the medical ...
Options are field-upgradable, allowing for cost-effective expansion to meet evolving analytical needs and future innovations. According to Bruker’s leadership team, the system offers flexibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results